Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Pending/in force |
21 | DE file number | DAKZ | 60 2017 049 596.4 |
96 | EP file number | EAKZ | 17 85 8944.6 |
86 | WO file number | WAKZ | PCT/US2017/054668 |
97 | EP publication number | EPN | 3509591 |
87 | WO publication number | WPN | 2018067422 |
54 | Designation/title | TI | NEUARTIGE JAK1-SELEKTIVE INHIBITOREN UND VERWENDUNGEN DAVON |
51 | IPC main class | ICM (ICMV) | C07D 491/147 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | C07D 491/048 (2006.01), A61K 31/437 (2006.01), A61P 19/02 (2006.01), A61K 31/4155 (2006.01), A61K 31/519 (2006.01) |
22 | DE application date | DAT | Sep 30, 2017 |
96 | EP application date | EAT | Sep 30, 2017 |
86 | WO application date | WAT | Sep 30, 2017 |
43 | Date of first publication | OT | Apr 12, 2018 |
| Date of publication of grant | PET | Nov 17, 2021 |
71/73 | Applicant/owner | INH | Hangzhou Highlightll Pharmaceutical Co., Ltd., Hangzhou, Zhejian, CN |
72 | Inventor | IN | LIANG, Congxin, Palm Beach Gardens, FL 33410, US |
| Address for service | | Dehns Patent and Trademark Attorneys, 80333 München, DE |
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 201662403660 P Oct 3, 2016
|
| Due date | FT FG | Sep 30, 2025 Annual fee for the 9th year
Patent fees |
| Patent division in charge | | 44 |
97 | EP language of publication | ELANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR |
| Published EP/WO documents | EPWOPN | Original document:
EP000003509591A1 Searchable text:
EP000003509591A1 Original document:
EP000003509591B1 Searchable text:
EP000003509591B1 Original document:
WO002018067422 Searchable text:
WO002018067422 |
43 | Date of first publication | EVT | Apr 12, 2018 |
| Date of the first transfer into DPMAregister | EREGT | Jul 17, 2019 |
| Date of the (most recent) update in DPMAregister | REGT | Oct 2, 2024 (Show all update days)(Hide all update days)- Oct 2, 2024
- Sep 26, 2024
- St.36: changed (technical change)
- Jun 13, 2024; May 2, 2024; Oct 3, 2023; Nov 10, 2022; Oct 6, 2022; Sep 23, 2022; May 26, 2022; May 10, 2022; Dec 9, 2021; Nov 10, 2021; Nov 3, 2021; Oct 28, 2021; Aug 23, 2019
- Historical data not available for this/these date(s)
- Jul 17, 2019
- Date of the first transfer into DPMAregister
|
View procedures New applicant/owner details (No.: 7)INID | Criterion | Field | Content
Close details
|
---|
| Type of procedure | VART | New applicant/owner details |
| Legal/procedural status | VST | New applicant/owner details |
| Date of legal/procedural status | VSTT | May 9, 2022 |
| Issue number | HN | 24 |
| Year | PJ | 2022 |
| Publication date | VT | Jun 15, 2022 |
| Type of publication | PART | Bibliographic data |
| Part | HT | Part 3 |
71/73 | Applicant/owner | INH | Hangzhou Highlightll Pharmaceutical Co., Ltd., Hangzhou, Zhejian, CN |
71/73 | Previous applicant/owner | INHF | Highlightll Pharmaceutical (Hainan) Co., Ltd., Hainan, 570000, CN |
| Date of update of the procedure | REGT | May 26, 2022 |